MEK inhibition sensitizes pancreatic cancer to STING agonism by tumor-cell intrinsic amplification of type I interferon signaling.
Razmik GhukasyanKeke LiangKevin ChauLuyi LiCharlotte ChanEvan R AbtThuc LeJoon Y ParkNanping WuAlykhan M PremjiRobert DamoiseauxTony LuuAmanda LaboraKhalid RashidJason M LinkCaius G RaduTimothy R DonahuePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Our results highlight the cytotoxic effects of STING agonism on PDAC cells that are independent of tumor immunity, and that these therapeutic benefits of STING agonism can be synergistically enhanced by MEK inhibition.